Blogs about Biotechnology, Pharmaceutical and Healthcare
Read the latest opinions - blogs from pharmaceutical and life science industry experts.
Showing News Articles 76–100 of 34,000+
BTG Makes Two Buys To Build Interventional Medicine Business
BTG of Britain plans two new acquisitions, including a therapy for liver cancer that uses radioactive glass beads and a treatment for dissolving severe blood clots. The deals create an interventional medicine business with potential sales of $1 billi...
Grifols big pharma deals Aradigm in licensing and option agreement for Pulmaquin, Lipoquin and AERx
Grifols, a big pharma company, has entered pharma deals with Aradigm for licensing and options relating to Pulmaquin, Lipoquin and AERx. Grifols and Aradigm announced the signing of pharma deals for the exclusive, worldwide license for Aradigm’s proprietary formulations of inhaled ciprofloxacin for the treatment of severe respiratory diseases, including non-cystic fibrosis bronchiectasis....
Birth control requirement in health law up for appeal
In the most prominent challenge of its kind, Hobby Lobby Stores Inc. is asking a federal appeals court Thursday for an exemption from part of the federal health care law that requires it to offer employees health coverage that includes access to the morning-after pill. The Ok …
Follow The 'Smart Money' And Buy Johnson & Johnson In The Next Pullback
By Hawkinvest:Shares of Johnson & Johnson (JNJ) have been in a solid uptrend throughout 2013. As shown in the chart below, the stock looks extended now, so investors should wait for a pullback. However, this company has many positives going for it which make it an ideal stock to buy in the next market correction. (click to enlarge) As the chart shows, Johnson & Johnson shares have advanc...
A medical first: Doctors save Ohio boy by ‘laser-printing’ an airway tube so he can breathe
In a medical first, doctors used plastic particles and a 3-D laser printer to create an airway splint to save the life of a baby boy who used to stop breathing nearly every day. It’s the latest advance from the booming field of regenerative med...
A fate worse than death for scores of African women
It’s a condition practically unheard of in the United States and most Western countries. But in a culture where a woman’s status and dignity is decided by her ability to provide a husband with multiple children, it can be a fate worse tha...
Comment on Could Pharma Do Tumblr? by Debbie Irwin
Interesting article, Peter. An opportunity for pharma marketers to create a bridge between medicine and millennials!
Why Merck Shares Are Cheap And Could Rise To $60
By Trade In Mexico:While many stocks are trading near 52-week highs or at stretched valuations, investors who selectively seek opportunities can find value in this market. For example, Merck (MRK) shares were trading at nearly $49, but a recent pullback to about $46, makes the stock worth buying for the generous dividend and the longer-term upside potential.Merck is a leading manufacturer of vacci...
Stem-cell cloner acknowledges errors in groundbreaking paper
A blockbuster paper that reported the creation of human stem cell lines via cloning has come under fire. An anonymous online commenter found four problems in the paper, which was published online 15 May in the journal Cell. (Nature)
Teen birth rates dip in all but 2 states, national figure at record low, CDC report says
The nation’s record-low teen birth rate stems from robust declines in nearly every state, but most dramatically in several Mountain States and among Hispanics, according to a new government report. (AP)
Fast new, one-step genetic engineering technology
A new, streamlined approach to genetic engineering drastically reduces the time and effort needed to insert new genes into bacteria, the workhorses of biotechnology, scientists are reporting. (Phys.org)
Judy MacDonald Johnson: Prepare for a good end of life
Thinking about death is frightening, but planning ahead is practical and leaves more room for peace of mind in our final days. In a solemn, thoughtful talk, Judy MacDonald Johnston shares 5 practices for planning for a good end of life. (TED Talk)
Greenway Adds Windows 8 Mobile Access to PrimeSUITE EHR
Greenway Medical Technologies has announced that PrimeMOBILE™, the mobile access solution for their PrimeSUITE® electronic health record customers, has been Microsoft-certified and is now available for download at the Windows 8 Store. The Windows...
Scientists warn against risking cerebral palsy stem cell treatment overseas
An expert panel of scientists and clinicians is warning people against going overseas for costly and unproven stem cell treatment for cerebral palsy. (ABC.net.au)
California stem-cell agency discloses grant-review conflict
Leroy Hood, head of a prominent research institute in Seattle, Washington, violated conflict-of-interest rules when he reviewed a friend’s grant, California’s stem-cell agency disclosed in a letter to the state legislature. (Nature)
WHO: 22 deaths from new SARS-like virus
The World Health Organization says there are now 22 deaths worldwide out of 44 lab-confirmed cases of the new coronavirus. WHO officials have reported another fatal case of the Middle East respiratory syndrome coronavirus, or MERS, in central Saudi Arabia, but say it is not r …
Heinrich Rohrer, physicist, dies at 79; helped open door to nanotechnology
Heinrich Rohrer, who shared the 1986 Nobel Prize in Physics for inventing a microscope that made it possible to see individual atoms and move them around, an achievement that led to vastly faster computing and greatly advanced molecular biology, died...
By EnhydrisPECorp:At the recent Bank of America Merrill Lynch 2013 Health Care Conference, Craig Audet Ph.D. gave an overview of Arena Pharmaceuticals' (ARNA) launch for Belviq, its FDA approved anti-obesity medication. While many longs felt that this presentation forecast $200 M first year sales for the drug, I took away a vastly different message. Based on the details provided at the conference...
H1N1 flu pandemic was deadliest for younger adults
The first analysis of the complete U.S. death records for the 2009-2010 H1N1 influenza pandemic was published Wednesday. It confirms what was widely observed at the time: The pandemic was deadliest for people under the age of 65.In fact, among people over the age of 65, the flu-related death rate actually declined during the pandemic.The University of California, Irvine, researchers who authored t...
Health Net's CEO Hosts 2013 Annual Shareholder Meeting (Transcript)
Health Net, Inc. (HNT)2013 Annual Shareholder Meeting May 23, 2013 1:00 pm ET Executives Roger F. Greaves - Chairman Angelee F. Bouchard - Senior Vice President, General Counsel and Secretary Jay M. Gellert - Chief Executive Officer, President and Director Angie McCabe - Vice President of Investor Relations Presentation Roger F. Greaves Well, good morning, everyone. It's my pleasure t...
Health Net, Inc. - Shareholder/Analyst Call
Health Net, Inc. (HNT) May 23, 2013 1:00 pm ET Executives Roger F. Greaves - Chairman Angelee F. Bouchard - Senior Vice President, General Counsel and Secretary Jay M. Gellert - Chief Executive Officer, President and Director Angie McCabe - Vice President of Investor Relations Presentation Roger F. Greaves Well, good morning, everyone. It's my pleasure to welcome you to the 2013 Annua...
New Survey: Market Access Trends in 2013
By Michelle Vitko, Senior Research Analyst In today’s pharmaceutical market, which is riddled with austerity measures and healthcare reform, securing favorable reimbursement rates is more difficult than ever. Cutting Edge Information is kicking o...
NuVasive's CEO Hosts Annual Shareholder Meeting (Transcript)
NuVasive, Inc. (NUVA)2013 Annual Shareholder Meeting May 23, 2013 11:00 am ET Executives Alexis V. Lukianov - Chairman and Chief Executive Officer Jason M. Hannon - Executive Vice President of Corporate Development, General Counsel and Secretary Presentation Alexis V. Lukianov Okay. Well, good morning. I am Alex Lukianov, Chairman of CEO of NuVasive. My pleasure on behalf of the Board...
NuVasive, Inc. - Shareholder/Analyst Call
NuVasive, Inc. (NUVA) May 23, 2013 11:00 am ET Executives Alexis V. Lukianov - Chairman and Chief Executive Officer Jason M. Hannon - Executive Vice President of Corporate Development, General Counsel and Secretary Presentation Alexis V. Lukianov Okay. Well, good morning. I am Alex Lukianov, Chairman of CEO of NuVasive. My pleasure on behalf of the Board of Directors and officers of Nu...
Engineer helps pioneer flat spray-on optical lens
A University of British Columbia engineer and a team of U.S. researchers have made a breakthrough utilizing spray-on technology that could revolutionize the way optical lenses are made and used....
